GSA Capital Partners LLP Buys 6,676 Shares of Encompass Health Corporation $EHC

GSA Capital Partners LLP raised its stake in shares of Encompass Health Corporation (NYSE:EHC) by 87.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 14,353 shares of the company’s stock after purchasing an additional 6,676 shares during the quarter. GSA Capital Partners LLP’s holdings in Encompass Health were worth $1,523,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Encompass Health by 3,059,159.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after purchasing an additional 3,793,358 shares during the period. Alliancebernstein L.P. increased its holdings in shares of Encompass Health by 23.4% during the 3rd quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock worth $319,567,000 after purchasing an additional 476,564 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Encompass Health by 0.5% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,616,178 shares of the company’s stock worth $205,279,000 after purchasing an additional 7,349 shares during the period. Raymond James Financial Inc. increased its holdings in shares of Encompass Health by 34.8% during the 3rd quarter. Raymond James Financial Inc. now owns 1,541,336 shares of the company’s stock worth $195,780,000 after purchasing an additional 397,694 shares during the period. Finally, JPMorgan Chase & Co. increased its holdings in shares of Encompass Health by 5.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,410,335 shares of the company’s stock worth $179,141,000 after purchasing an additional 70,387 shares during the period. Institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Performance

NYSE EHC opened at $106.04 on Thursday. The stock has a market cap of $10.52 billion, a P/E ratio of 17.70, a PEG ratio of 2.28 and a beta of 0.72. The company’s 50-day simple moving average is $102.82 and its 200 day simple moving average is $105.88. Encompass Health Corporation has a twelve month low of $92.77 and a twelve month high of $127.99. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last posted its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. The business had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. The firm’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. As a group, research analysts forecast that Encompass Health Corporation will post 5.96 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, July 1st. Encompass Health’s dividend payout ratio is currently 12.69%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Barclays dropped their price objective on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, May 5th. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and an average price target of $144.17.

Insider Activity

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the company’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $104.56, for a total transaction of $71,309.92. Following the sale, the executive vice president directly owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. This represents a 2.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Treasurer Edmund Fay sold 11,937 shares of the company’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the sale, the treasurer directly owned 89,325 shares in the company, valued at $9,557,775. This represents a 11.79% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.80% of the stock is currently owned by corporate insiders.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.